JPS5533408A - Immunity-increasing agent - Google Patents
Immunity-increasing agentInfo
- Publication number
- JPS5533408A JPS5533408A JP10484578A JP10484578A JPS5533408A JP S5533408 A JPS5533408 A JP S5533408A JP 10484578 A JP10484578 A JP 10484578A JP 10484578 A JP10484578 A JP 10484578A JP S5533408 A JPS5533408 A JP S5533408A
- Authority
- JP
- Japan
- Prior art keywords
- lysozyme
- immunity
- diseases
- agent
- bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010014251 Muramidase Proteins 0.000 abstract 6
- 102000016943 Muramidase Human genes 0.000 abstract 6
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract 6
- 229960000274 lysozyme Drugs 0.000 abstract 6
- 235000010335 lysozyme Nutrition 0.000 abstract 6
- 239000004325 lysozyme Substances 0.000 abstract 6
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 241000894006 Bacteria Species 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000012657 Atopic disease Diseases 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 101001018100 Homo sapiens Lysozyme C Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000003327 cancerostatic effect Effects 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 230000001079 digestive effect Effects 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000001524 infective effect Effects 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10484578A JPS5533408A (en) | 1978-08-30 | 1978-08-30 | Immunity-increasing agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10484578A JPS5533408A (en) | 1978-08-30 | 1978-08-30 | Immunity-increasing agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5533408A true JPS5533408A (en) | 1980-03-08 |
| JPS6365653B2 JPS6365653B2 (enrdf_load_stackoverflow) | 1988-12-16 |
Family
ID=14391656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10484578A Granted JPS5533408A (en) | 1978-08-30 | 1978-08-30 | Immunity-increasing agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5533408A (enrdf_load_stackoverflow) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP628A (en) * | 1995-01-13 | 1998-02-27 | Nika Health Products | New applications of lysozyme dimer. |
| US6123937A (en) * | 1997-03-14 | 2000-09-26 | Nika Health Products, Limited | Applications of lysozyme dimer |
| US6132715A (en) * | 1992-04-08 | 2000-10-17 | Nika Health Products Limited | Method of inhibiting biosynthesis of tumor necrosis factor |
| US6183742B1 (en) | 1992-07-13 | 2001-02-06 | Nika Health Products, Limited | Applications of lysozyme dimer |
| WO2003103621A1 (fr) * | 2002-06-05 | 2003-12-18 | Changchun Qilong Technology Research Institution | Serie de produits cosmetiques a base de lysozyme humain (hlz) et methode de fabrication |
| JP2005530841A (ja) * | 2002-06-19 | 2005-10-13 | シーテイエス・ケミカル・インダストリーズ・リミテツド | 発泡性経口投与形態 |
| WO2008043767A1 (en) * | 2006-10-11 | 2008-04-17 | Thereapicon Srl | Antimetastatic effect on human cell disorders |
-
1978
- 1978-08-30 JP JP10484578A patent/JPS5533408A/ja active Granted
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6132715A (en) * | 1992-04-08 | 2000-10-17 | Nika Health Products Limited | Method of inhibiting biosynthesis of tumor necrosis factor |
| US6183742B1 (en) | 1992-07-13 | 2001-02-06 | Nika Health Products, Limited | Applications of lysozyme dimer |
| AP628A (en) * | 1995-01-13 | 1998-02-27 | Nika Health Products | New applications of lysozyme dimer. |
| AP871A (en) * | 1995-01-13 | 2000-09-10 | Nika Health Products | New applicants of lysozyme dimer. |
| US6123937A (en) * | 1997-03-14 | 2000-09-26 | Nika Health Products, Limited | Applications of lysozyme dimer |
| WO2003103621A1 (fr) * | 2002-06-05 | 2003-12-18 | Changchun Qilong Technology Research Institution | Serie de produits cosmetiques a base de lysozyme humain (hlz) et methode de fabrication |
| JP2005530841A (ja) * | 2002-06-19 | 2005-10-13 | シーテイエス・ケミカル・インダストリーズ・リミテツド | 発泡性経口投与形態 |
| WO2008043767A1 (en) * | 2006-10-11 | 2008-04-17 | Thereapicon Srl | Antimetastatic effect on human cell disorders |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6365653B2 (enrdf_load_stackoverflow) | 1988-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE31625T1 (de) | Pharmazeutisches mittel zur behandlung des diabetes mellitus. | |
| NO154582C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider. | |
| JPS5533408A (en) | Immunity-increasing agent | |
| NO307689B1 (no) | Anvendelse av et antimikrobielt middel | |
| RU98101105A (ru) | Новое применение в медицинских целях | |
| ATE40793T1 (de) | Pharmazeutisches praeparat zur therapeutischen behandlung von rheumatischen erkrankungen. | |
| JPS57126420A (en) | Drug for digestive organ | |
| RU93003792A (ru) | Препарат для лечения заболеваний желудка, связанных с секреторной недостаточностью, на основе куриного пепсина | |
| JPS51141279A (en) | Method of improving physical constitution of cattle | |
| MA21895A1 (fr) | Association de vitamine "a" a dose physiologique et differents principes actifs . | |
| IL57513A0 (en) | 1,3-diaminopropan-2-ol derivatives,their preparation and pharmaceutical compositions containing them | |
| RU93051046A (ru) | Способ борьбы с аскосферозом и гнильцовыми болезнями пчел | |
| JPS54154515A (en) | Slowly releasing drug | |
| NO821083L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater | |
| Lee et al. | Teratogenicity Study of Food Additives Chemicals in the Developing Chick Embryo | |
| JPH0132209B2 (enrdf_load_stackoverflow) | ||
| DE59107405D1 (de) | Ein Imidazobenzodiazepin zur Behandlung von Schlafstörungen | |
| Anderson | The common cold | |
| JPS6137251B2 (enrdf_load_stackoverflow) | ||
| Teton et al. | About poisonous and venomous fishes. Stinging by stone-fishes: clinic, treatment and conclusions). | |
| Gillett | Low Fecundity | |
| Parry | The Common Cold | |
| SU1046995A1 (ru) | Способ профилактики пуллороза птиц | |
| JPH0133447B2 (enrdf_load_stackoverflow) | ||
| JPS57105423A (en) | Chloroethylureidopropylpolysilsesquioxane |